Springer
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
Product Code:
9783319679303
ISBN13:
9783319679303
Condition:
New
$180.44
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
$180.44
Comprehensively covers the multiplicity and diversity of mechanisms underlying resistance to the currently approved drugs, both tyrosine kinase inhibitors and monoclonal antibodies, that specifically inhibit growth factor receptors playing driver or survival functions in cancerExamines specific targets and the cognate drugsEvaluates molecular modes of innate and evolving resistance
| Author: Yosef Yarden |
| Publisher: Springer |
| Publication Date: Apr 10, 2018 |
| Number of Pages: 242 pages |
| Binding: Hardback or Cased Book |
| ISBN-10: 3319679309 |
| ISBN-13: 9783319679303 |
Related Products
Createspace Independent Publishing Platform
TYROSINE KINASE INHIBITORS in MANAGEMENT of AGGRESSIVE DIFFERENTIATED THYROID CANCER
$17.52